IL10 and cancer: Tumour and peripheral blood MDSCs isolated from human CRC cancer patients potently inhibited T cell proliferation ex vivo, and pharmacological inhibition of IL-10 but not Arg1 of iNOS reversed the immunosuppressive effect of MDSCs in a human CRC study [103].